Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo

被引:94
作者
Schnorr, Oliver [1 ]
Brossette, Tatjana [1 ]
Momma, Tony Y. [2 ]
Kleinbongard, Petra [3 ]
Keen, Carl L. [2 ]
Schroeter, Hagen [2 ]
Sies, Helmut [1 ]
机构
[1] Univ Dusseldorf, Inst Biochem & Mol Biol 1, D-40225 Dusseldorf, Germany
[2] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[3] Rhein Westfal TH Aachen, Univ Hosp, Med Clin 1, Aachen, Germany
关键词
arginase; cocoa; flavanols; L-arginine; erythrocytes; nitric oxide; endothelium; (-)-epicatechin;
D O I
10.1016/j.abb.2008.02.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The availability Of L-arginine can be a rate-limiting factor for cellular NO production by nitric oxide synthases (NOS). Arginase competes with NOS for L-arginine as the common substrate. Increased arginase activity has been linked to low NO levels, and an inhibition of arginase activity has been reported to improve endothelium-dependent vasorelaxation. Based on the above, we hypothesized that an increase in the circulating NO pool following flavanol consumption could be correlated with decreased arginase activity. To test this hypothesis we (a) investigated the effects of (-)-epicatechin and its structurally related metabolites on endothelial arginase expression and activity in vitro; (b) evaluated the effects of dietary flavanol-rich cocoa on kidney arginase activity in vivo; and (c) assessed human erythrocyte arginase activity following flavanol-rich cocoa beverage consumption in a double-blind intervention study with cross-over design. The results demonstrate that cocoa flavanols lower arginase-2 mRNA expression and activity in HUVEC. Dietary intervention with flavanol-rich cocoa caused diminished arginase activity in rat kidney and, erythrocyte arginase activity was lowered in healthy humans following consumption of a high flavanol beverage in vivo. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 34 条
[1]   Flavanols and cardiovascular health: Effects on the circulating NO pool in humans [J].
Balzer, Jan ;
Heiss, Christian ;
Schroeter, Hagen ;
Brouzos, Paris ;
Kleinbongard, Petra ;
Matern, Simone ;
Lauer, Thomas ;
Rassaf, Tienush ;
Kelm, Malte .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 :S122-S127
[2]  
Bergmeyer H U, 1972, Quad Sclavo Diagn, V8, P27
[3]   Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels [J].
Berkowitz, DE ;
White, R ;
Li, DC ;
Minhas, KM ;
Cernetich, A ;
Kim, S ;
Burke, S ;
Shoukas, AA ;
Nyhan, D ;
Champion, HC ;
Hare, JM .
CIRCULATION, 2003, 108 (16) :2000-2006
[4]  
BROWN GW, 1959, J BIOL CHEM, V234, P1769
[5]   Increased nitric oxide synthesis in uraemic platelets is dependent on L-arginine transport via system y+L [J].
Brunini, TMC ;
Yaqoob, MM ;
Malagris, LEN ;
Ellory, JC ;
Mann, GE ;
Ribeiro, ACM .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2003, 445 (05) :547-550
[6]   DETERMINATION OF ARGINASE ACTIVITY IN MACROPHAGES - A MICROMETHOD [J].
CORRALIZA, IM ;
CAMPO, ML ;
SOLER, G ;
MODOLELL, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 174 (1-2) :231-235
[7]   Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats [J].
Demougeot, C ;
Prigent-Tessier, A ;
Marie, C ;
Berthelot, A .
JOURNAL OF HYPERTENSION, 2005, 23 (05) :971-978
[8]  
ENSUNSA JL, 1994, EXP BIOL MED, V229, P1143
[9]   Chromosomal localization of the human arginase II gene and tissue distribution of its mRNA [J].
Gotoh, T ;
Araki, M ;
Mori, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (02) :487-491
[10]   Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase [J].
Hein, TW ;
Zhang, CH ;
Wang, W ;
Chang, CI ;
Thengchaisri, N ;
Kuo, L .
FASEB JOURNAL, 2003, 17 (13) :2328-+